Feliksas Jankevicius

Santariskiu St. 2
Vilnius, VL LT08661, Lithuania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Biomimetic multilayered hydrogel scaffold with dual cell types and mesh support for urethral reconstruction.

Biomimetic multilayered hydrogel scaffold with dual cell types and mesh support for urethral reconstruction.

Journal: Biofabrication

Published: August 03, 2026

Comparison of prostate cancer diagnostic models based on PCA3 and TMPRSS2:ERG RNA biomarkers from post-DRE and non-DRE urine specimens.

Comparison of prostate cancer diagnostic models based on PCA3 and TMPRSS2:ERG RNA biomarkers from post-DRE and non-DRE urine specimens.

Journal: World journal of urology

Published: January 27, 2026

Spatially-resolved CD8+ and CD34+ computational immunohistochemistry indicators improve post-nephrectomy risk stratification in clear cell renal cell carcinoma.

Spatially-resolved CD8+ and CD34+ computational immunohistochemistry indicators improve post-nephrectomy risk stratification in clear cell renal cell carcinoma.

Journal: Human pathology

Published: January 08, 2026

Biomimetic multilayered hydrogel scaffold with dual cell types and mesh support for urethral reconstruction.

Biomimetic multilayered hydrogel scaffold with dual cell types and mesh support for urethral reconstruction.

Journal: Biofabrication

Published: October 31, 2025

Computational pathology model to predict recurrence-free survival in NMPUC patients on BCG-therapy.

Computational pathology model to predict recurrence-free survival in NMPUC patients on BCG-therapy.

Journal: NPJ precision oncology

Published: April 16, 2025

Spatial Distribution of Macrophage and Lymphocyte Subtypes within Tumor Microenvironment to Predict Recurrence of Non-Muscle-Invasive Papillary Urothelial Carcinoma after BCG Immunotherapy.

Spatial Distribution of Macrophage and Lymphocyte Subtypes within Tumor Microenvironment to Predict Recurrence of Non-Muscle-Invasive Papillary Urothelial Carcinoma after BCG Immunotherapy.

Journal: International journal of molecular sciences

Published: March 27, 2024

Prediction of Non-Muscle Invasive Papillary Urothelial Carcinoma Relapse from Hematoxylin-Eosin Images Using Deep Multiple Instance Learning in Patients Treated with Bacille Calmette-Guérin Immunotherapy.

Prediction of Non-Muscle Invasive Papillary Urothelial Carcinoma Relapse from Hematoxylin-Eosin Images Using Deep Multiple Instance Learning in Patients Treated with Bacille Calmette-Guérin Immunotherapy.

Journal: Biomedicines

Published: December 28, 2023

Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer.

Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer.

Journal: Medicina (Kaunas, Lithuania)

Published: December 01, 2023

Combination of DNA methylation biomarkers with multiparametric magnetic resonance and ultrasound imaging fusion biopsy to detect the local spread of prostate cancer.

Combination of DNA methylation biomarkers with multiparametric magnetic resonance and ultrasound imaging fusion biopsy to detect the local spread of prostate cancer.

Journal: The Prostate

Published: April 16, 2023

Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies.

Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies.

Journal: Medicina (Kaunas, Lithuania)

Published: February 08, 2023

Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients.

Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients.

Journal: Biomedicines

Published: January 12, 2023

CD8+ Cell Density Gradient across the Tumor Epithelium-Stromal Interface of Non-Muscle Invasive Papillary Urothelial Carcinoma Predicts Recurrence-Free Survival after BCG Immunotherapy.

CD8+ Cell Density Gradient across the Tumor Epithelium-Stromal Interface of Non-Muscle Invasive Papillary Urothelial Carcinoma Predicts Recurrence-Free Survival after BCG Immunotherapy.

Journal: Cancers

Published: December 21, 2022

Showing 1-12 of 51

Last Updated: 09/26/2026